Growth Metrics

Merck (MRK) FCF Margin (2016 - 2026)

Merck has reported FCF Margin over the past 18 years, most recently at 17.97% for Q1 2026.

  • Quarterly FCF Margin rose 1043.0% to 17.97% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 21.46% through Mar 2026, down 519.0% year-over-year, with the annual reading at 19.01% for FY2025, 919.0% down from the prior year.
  • FCF Margin was 17.97% for Q1 2026 at Merck, up from 11.12% in the prior quarter.
  • Over five years, FCF Margin peaked at 51.08% in Q3 2024 and troughed at 5.08% in Q4 2023.
  • The 5-year median for FCF Margin is 18.22% (2023), against an average of 21.23%.
  • Year-over-year, FCF Margin soared 2227bps in 2022 and then tumbled -2880bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 23.72% in 2022, then tumbled by -121bps to 5.08% in 2023, then skyrocketed by 417bps to 16.08% in 2024, then crashed by -31bps to 11.12% in 2025, then surged by 62bps to 17.97% in 2026.
  • Per Business Quant, the three most recent readings for MRK's FCF Margin are 17.97% (Q1 2026), 11.12% (Q4 2025), and 39.56% (Q3 2025).